aflac inc. - AFL
AFL
Close Chg Chg %
110.77 -0.99 -0.89%
Closed Market
109.78
-0.99 (0.89%)
Volume: 1.88M
Last Updated:
Mar 28, 2025, 3:59 PM EDT
Company Overview: aflac inc. - AFL
AFL Key Data
| Open $110.60 | Day Range 109.24 - 111.42 |
| 52 Week Range 79.31 - 115.50 | Market Cap $60.47B |
| Shares Outstanding 545.82M | Public Float 489.47M |
| Beta 0.93 | Rev. Per Employee N/A |
| P/E Ratio 11.46 | EPS $9.65 |
| Yield 188.34% | Dividend $0.58 |
| EX-DIVIDEND DATE Feb 19, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.01M |
AFL Performance
| 1 Week | 1.44% | ||
| 1 Month | 0.30% | ||
| 3 Months | 6.21% | ||
| 1 Year | 27.88% | ||
| 5 Years | 210.17% |
AFL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
18
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 102.923 | |
| Number of Ratings | 18 | Current Quarters Estimate | 1.681 | |
| FY Report Date | 03 / 2025 | Current Year's Estimate | 6.782 | |
| Last Quarter’s Earnings | 1.56 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 7.21 | Next Fiscal Year Estimate | 7.172 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 15 | 15 | 16 | 16 |
| Mean Estimate | 1.68 | 1.72 | 6.78 | 7.17 |
| High Estimates | 1.81 | 1.82 | 7.25 | 7.80 |
| Low Estimate | 1.51 | 1.65 | 6.38 | 6.71 |
| Coefficient of Variance | 3.94 | 3.00 | 3.78 | 4.24 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 2 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 12 | 11 | 10 |
| UNDERWEIGHT | 0 | 1 | 1 |
| SELL | 3 | 3 | 3 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Aflac Inc. - AFL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Aflac Inc. - AFL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 12, 2025 | Charles Ditmars Lake Chairman & Rep. Director, ALIJ | 68,225 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $106.61 per share | 7,273,467.25 |
| Mar 12, 2025 | Charles Ditmars Lake Chairman & Rep. Director, ALIJ | 52,362 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $107.62 per share | 5,635,198.44 |
| Mar 12, 2025 | Charles Ditmars Lake Chairman & Rep. Director, ALIJ | 49,962 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $108.4 per share | 5,415,880.80 |
| Mar 12, 2025 | Charles Ditmars Lake Chairman & Rep. Director, ALIJ | 79,764 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $107.63 per share | 8,584,999.32 |
| Mar 11, 2025 | Masatoshi Koide Pres. and Rep. Director, ALIJ | 107,992 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $107.63 per share | 11,623,178.96 |
| Mar 11, 2025 | Joseph L. Moskowitz Director | 25,393 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $107.63 per share | 2,733,048.59 |
| Feb 24, 2025 | Audrey Boone Tillman Sr. Executive Vice President | 257,668 | Bona fide gift | 0.00 |
| Feb 13, 2025 | Frederic Jean Guy Simard EVP, COO & CFO, Aflac U.S. | 579 | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acq or disposition of issuer shs Non-derivative transaction at $103.58 per share | 59,972.82 |
| Feb 13, 2025 | Robin L. Blackmon SVP, Chief Accounting Officer | 6,946 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $102.61 per share | 712,729.06 |
| Jun 26, 2024 | Virgil R. Miller President, Aflac U.S. | 7,729 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $90.43 per share | 698,933.47 |
| May 9, 2024 | Katherine T. Rohrer Director | 21,380 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 9, 2024 | Katherine T. Rohrer Director | 20,480 | Bona fide gift | 0.00 |
| May 9, 2024 | Miwako Hosoda Director | 5,656 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 9, 2024 | William Paul Bowers Director | 66,842 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Karole F. Lloyd Director | 47,036 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Arthur R. Collins Director | 7,732 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Thomas J. Kenny Director | 20,046 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Georgette D. Kiser Director | 17,518 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Nobuchika Mori Director | 12,526 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 6, 2024 | Max K. Brodén EVP, Chief Financial Officer | 235 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $76.31 per share | 17,932.85 |
Aflac Inc. in the News
Aflac CEO says company adapted to health care in a 'post-COVID world'
The insurance industry has made some changes in the wake of COVID-19, and as patients needs evolve with time and medical recommendations, Aflac CEO Dan Amos said.
Aflac CEO says inflation is impacting Americans’ ability to afford ‘higher costs of health care’
Aflac Chairman and CEO Dan Amos says the insurance company will offer a higher premium policy "option" as inflation takes control of Americans' "purse strings."